Huntington Bancshares (NASDAQ:HBAN) Price Target Raised to $13.00 at Morgan Stanley
Huntington Bancshares (NASDAQ:HBAN – Free Report) had its price target boosted by Morgan Stanley from $12.00 to $13.00 in a report released on Monday, Benzinga...
CytoMed Therapeutics (NASDAQ:GDTC) Stock Rating Reaffirmed by Benchmark
Benchmark reaffirmed their speculative buy rating on shares of CytoMed Therapeutics (NASDAQ:GDTC – Free Report) in a report issued on Monday morning, Benzinga reports. Benchmark...
Fluence Energy (NASDAQ:FLNC) Lifted to “Buy” at Roth Capital
Roth Capital upgraded shares of Fluence Energy (NASDAQ:FLNC – Free Report) from a neutral rating to a buy rating in a research report report published...
Hologic (NASDAQ:HOLX) Raised to “Buy” at StockNews.com
StockNews.com upgraded shares of Hologic (NASDAQ:HOLX – Free Report) from a hold rating to a buy rating in a research report released on Tuesday morning....
BRP (TSE:DOO) Downgraded by UBS Group
UBS Group cut shares of BRP (TSE:DOO – Free Report) from a buy rating to a neutral rating in a research report sent to investors...
CVS Group (LON:CVSG) Given Outperform Rating at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of CVS Group (LON:CVSG – Free Report) in a research report sent to investors on...